234 related articles for article (PubMed ID: 17637014)
1. Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership.
Yang Y; Faustino PJ; Volpe DA; Ellison CD; Lyon RC; Yu LX
Mol Pharm; 2007; 4(4):608-14. PubMed ID: 17637014
[TBL] [Abstract][Full Text] [Related]
2. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
[TBL] [Abstract][Full Text] [Related]
3. Transepithelial transport of biperiden hydrochloride in Caco-2 cell monolayers.
Abalos IS; Rodríguez YI; Lozano V; Cereseto M; Mussini MV; Spinetto ME; Chiale C; Pesce G
Environ Toxicol Pharmacol; 2012 Sep; 34(2):223-227. PubMed ID: 22554863
[TBL] [Abstract][Full Text] [Related]
4. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
[TBL] [Abstract][Full Text] [Related]
5. [Biopharmaceutics classification and absorption mechanisms primary study on four kinds of flavonoids].
Li HF; Zhang D; Qu WJ; Wang HL; Liu Y; Borjigdai A; Cui J; Dong ZQ
Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(7):1198-1203. PubMed ID: 28879731
[TBL] [Abstract][Full Text] [Related]
6. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
[TBL] [Abstract][Full Text] [Related]
7. Biopharmaceutics permeability classification of lorcaserin, a selective 5-hydroxytryptamine 2C agonist: method suitability and permeability class membership.
Chen C; Ma MG; Fullenwider CL; Chen WG; Sadeque AJ
Mol Pharm; 2013 Dec; 10(12):4739-45. PubMed ID: 24102111
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay.
Thiel-Demby VE; Humphreys JE; St John Williams LA; Ellens HM; Shah N; Ayrton AD; Polli JW
Mol Pharm; 2009; 6(1):11-8. PubMed ID: 19248229
[TBL] [Abstract][Full Text] [Related]
9. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system.
Lentz KA; Hayashi J; Lucisano LJ; Polli JE
Int J Pharm; 2000 Apr; 200(1):41-51. PubMed ID: 10845684
[TBL] [Abstract][Full Text] [Related]
10. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.
Rinaki E; Valsami G; Macheras P
Pharm Res; 2003 Dec; 20(12):1917-25. PubMed ID: 14725354
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
[TBL] [Abstract][Full Text] [Related]
12. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation.
Zur M; Hanson AS; Dahan A
Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076
[TBL] [Abstract][Full Text] [Related]
13. Qualification of In Vitro Dissolution Absorption System 2 (IDAS2) with Caco-2 and MDCK Cell Monolayers: Dose Sensitivity Study Using BCS Class I and III Drugs.
Higashino H; Develin CF; Higashino C; Lim TC; Miezeiewski BJ; Rawa SL; Strab RJ; Patel R; Bhoopathy S
Biol Pharm Bull; 2024; 47(6):1123-1127. PubMed ID: 38839364
[TBL] [Abstract][Full Text] [Related]
14. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
Zur M; Cohen N; Agbaria R; Dahan A
Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
[TBL] [Abstract][Full Text] [Related]
15. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
Zhang SY; Ong WSY; Subelzu N; Gleeson JP
Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutic Risk Assessment of Brand and Generic Lamotrigine Tablets.
Vaithianathan S; Raman S; Jiang W; Ting TY; Kane MA; Polli JE
Mol Pharm; 2015 Jul; 12(7):2436-43. PubMed ID: 26001027
[TBL] [Abstract][Full Text] [Related]
17. Matrix effects of the hydroethanolic extract and the butanol fraction of calyces from Physalis peruviana L. on the biopharmaceutics classification of rutin.
Domínguez Moré GP; Feltrin C; Brambila PF; Cardona MI; Echeverry SM; Simões CMO; Aragón DM
J Pharm Pharmacol; 2020 May; 72(5):738-747. PubMed ID: 32162346
[TBL] [Abstract][Full Text] [Related]
18. Is the full potential of the biopharmaceutics classification system reached?
Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
[TBL] [Abstract][Full Text] [Related]
19. Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Li H; Cao X; Liu Y; Liu T; Wang M; Ren X; Dou Z
J Ethnopharmacol; 2019 Nov; 244():112148. PubMed ID: 31400507
[TBL] [Abstract][Full Text] [Related]
20. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
